Category Archive for Interesting Reads
For opinion pieces and round-ups
AMA pushes for transparency in coronavirus vaccine effort
The American Medical Association (AMA) has cautioned the US Food and Drug Administration (FDA) to ensure its assessment of vaccines … read more »
Pharma presents drug pricing plans to White House
Reports say that the pharmaceutical industry has presented its own plan to reduce drugs spend in the USA in an … read more »
Reports: China sets-out rules for vaccine approval
China’s National Medical Products Administration (NMPA) has reportedly revealed its criteria for approving COVID-19 vaccines for use. According to Fierce … read more »
USA: Analysis shows States pushing ahead with pricing legislation
A new analysis by Deloitte has shown that States across America have been progressing various forms of drug pricing legislation, … read more »
IFPMA and pharma firms create fund to help tackle AMR
IFPMA and at least 24 major pharmaceutical companies have formed a new investment organisation to support development of drugs against … read more »
Companies lose pricing powers in Pakistan
Reports say that Prime Minister Imran Khan has instructed the Government to reform pharmaceutical pricing, removing the ability of companies … read more »
ICER delves into potential funding models for COVID-19 products
The Institute for Clinical and Economic Review (ICER) has examined a range of funding models that could be used for … read more »
SMC suspends meetings during COVID-19 pandemic
The SMC has indefinitely suspended meetings of its SMC Committee and New Drugs Committee until further notice as a result … read more »
New UK ‘RAPID-C19’ coordination body launched to support access for COVID therapies
The UK has announced a new collaboration initiative to triage, coordinate, and fast-track potential COVID-19 therapies. The RAPID-C19 (Research to … read more »
IVIg-G product approved for phase 3 COVID-19 trial
Octagam, an intravenous immunoglobulin-G (IVIg-G) product has received approval for a phase 3 trial to reduce the effects of COVID-19. … read more »
